Ralf Dechend Selected Research

Pre-Eclampsia (Preeclampsia)

1/2021	Circulating HLA-G and its association with cardiovascular markers in pregnancy.
1/2021	Circulating Maternal sFLT1 (Soluble fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse Model.
1/2021	Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia.
10/2020	High-sensitivity cardiac troponin I in women with a history of early-onset preeclampsia.
4/2020	Prediction of birth weight small for gestational age with and without preeclampsia by angiogenic markers: an Odense Child Cohort study.
1/2020	Statins Reverse Postpartum Cardiovascular Dysfunction in a Rat Model of Preeclampsia.
1/2020	Multiplex Analysis of Circulating Maternal Cardiovascular Biomarkers Comparing Preeclampsia Subtypes.
1/2020	Blockade of endogenous angiotensin II type I receptor agonistic autoantibody activity improves mitochondrial reactive oxygen species and hypertension in a rat model of preeclampsia.
12/2019	Systemic Outcomes of (Pyr1)-Apelin-13 Infusion at Mid-Late Pregnancy in a Rat Model with Preeclamptic Features.
1/2019	Regulatory antibodies against GPCR in women ten years after early-onset preeclampsia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ralf Dechend Research Topics

Disease

79	Pre-Eclampsia (Preeclampsia) 01/2021 - 04/2003
62	Hypertension (High Blood Pressure) 01/2022 - 12/2002
17	Inflammation (Inflammations) 01/2022 - 01/2002
17	Albuminuria 04/2021 - 01/2002
13	Fibrosis (Cirrhosis) 01/2020 - 11/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2008
12	Ischemia 12/2019 - 09/2002
8	Cardiomegaly (Heart Hypertrophy) 01/2020 - 01/2005
7	Heart Failure 01/2020 - 02/2005
7	Proteinuria 12/2019 - 06/2008
6	Body Weight (Weight, Body) 12/2021 - 11/2007
6	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2020 - 08/2010
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 04/2011
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2012
4	Hypoxia (Hypoxemia) 01/2019 - 07/2009
4	Diabetes Mellitus 01/2018 - 07/2009
3	Thrombosis (Thrombus) 12/2019 - 07/2007
3	Alzheimer Disease (Alzheimer's Disease) 12/2018 - 11/2013
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2018 - 10/2012
3	Necrosis 11/2015 - 09/2002
3	Atrial Remodeling 11/2014 - 08/2007
3	Vascular System Injuries 12/2012 - 02/2002
2	Insulin Resistance 01/2022 - 03/2007
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2021 - 07/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 07/2011
2	Stroke (Strokes) 01/2021 - 01/2018
2	Birth Weight (Birth Weights) 04/2020 - 01/2019
2	Hypertrophy 01/2020 - 02/2005
2	Bradycardia 01/2020 - 09/2008
2	Atherosclerosis 12/2019 - 07/2003
2	Ovarian Neoplasms (Ovarian Cancer) 12/2018 - 01/2016
2	Ovarian Epithelial Carcinoma 06/2018 - 01/2016
2	Glucose Intolerance 01/2018 - 03/2009
2	Neoplasms (Cancer) 01/2016 - 03/2008
2	Edema (Dropsy) 11/2015 - 02/2010
2	Hemolysis 02/2015 - 05/2013
2	HELLP Syndrome 02/2015 - 05/2013
2	Infections 11/2014 - 07/2003
2	Obesity 07/2011 - 03/2009
2	Cardiomyopathies (Cardiomyopathy) 01/2008 - 11/2007

Drug/Important Bio-Agent (IBA)

34	Angiotensin IIIBA 01/2020 - 01/2002
32	AutoantibodiesIBA 01/2022 - 11/2004
15	ReninIBA 01/2020 - 02/2005
13	AntibodiesIBA 01/2022 - 11/2004
13	AngiotensinsIBA 01/2021 - 02/2002
11	Biomarkers (Surrogate Marker)IBA 04/2021 - 02/2009
10	AngiotensinogenIBA 01/2021 - 02/2005
10	Type 1 Angiotensin ReceptorIBA 01/2020 - 03/2007
9	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 09/2004
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 07/2003
8	aliskiren FDA Link 10/2016 - 09/2005
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012 - 09/2005
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2020 - 01/2012
7	NF-kappa B (NF-kB)IBA 01/2020 - 01/2002
7	SaltsIBA 01/2020 - 01/2005
7	Proteins (Proteins, Gene)FDA Link 05/2017 - 07/2003
7	CytokinesIBA 08/2014 - 12/2008
6	Endothelin-1 (Endothelin 1)IBA 01/2019 - 10/2009
6	Vitamin D FDA LinkGeneric 01/2017 - 04/2013
5	Phosphotransferases (Kinase)IBA 04/2020 - 07/2011
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 03/2002
4	Insulin (Novolin)FDA Link 01/2022 - 10/2015
4	SodiumIBA 01/2022 - 03/2014
4	Messenger RNA (mRNA)IBA 05/2017 - 12/2002
4	Interleukin-6 (Interleukin 6)IBA 12/2016 - 03/2007
4	Atrial Natriuretic Factor (ANF)IBA 04/2013 - 09/2005
4	Losartan (Cozaar)FDA LinkGeneric 05/2012 - 02/2005
4	Thromboplastin (Tissue Factor)IBA 02/2006 - 12/2002
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 08/2012
3	Connective Tissue Growth FactorIBA 04/2021 - 03/2007
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 04/2013
3	Insulin ReceptorIBA 01/2021 - 01/2017
3	LeptinIBA 01/2021 - 06/2009
3	Prorenin ReceptorIBA 01/2020 - 01/2016
3	C-Reactive ProteinIBA 01/2018 - 09/2005
3	GTP-Binding Proteins (G-Protein)IBA 03/2014 - 03/2013
3	Transcription Factors (Transcription Factor)IBA 11/2007 - 02/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 12/2018
2	AlbuminsIBA 12/2021 - 01/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2019 - 11/2002
2	Immunoglobulin G (IgG)IBA 12/2018 - 02/2005
2	Doxycycline (Periostat)FDA LinkGeneric 01/2018 - 08/2010
2	Interleukin-10 (Interleukin 10)IBA 11/2017 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 03/2007
2	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 07/2009
2	Retinaldehyde (Retinal)IBA 01/2017 - 01/2016
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2017 - 08/2010
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2016 - 02/2015
2	RelaxinIBA 01/2016 - 01/2014
2	AntioxidantsIBA 10/2015 - 10/2004
2	EnzymesIBA 02/2015 - 05/2013
2	salicylhydroxamic acid (SHAM)IBA 02/2015 - 09/2002
2	Peptides (Polypeptides)IBA 11/2013 - 12/2012
2	AdipokinesIBA 07/2011 - 06/2009
2	CreatinineIBA 09/2005 - 02/2002
2	Ventricular MyosinsIBA 09/2005 - 02/2005

Therapy/Procedure

3	Therapeutics 01/2022 - 10/2016
2	Cesarean Section (Caesarean Section) 01/2018 - 01/2018